GlaxoSmithKline Pharmaceuticals Limited(IN:GLAXO)
₹2,714.65+76.65 (+2.91%)
IN:GLAXO
GlaxoSmithKline Pharmaceuticals Limited financials statements
₹2,714.65
At close:+76.65 (+2.91%)
Want to see IN:GLAXO full AI Analyst Report?
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement
7 Followers
GlaxoSmithKline Pharmaceuticals Limited Income Statement
Last quarter (Q2 2027), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹11.84B, an increase of 20.78% from the same quarter last year. In Q2, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹3.36B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| ₹ 38.22B | ₹ 37.26B | ₹ 34.42B | ₹ 32.26B | ₹ 32.64B | |
| ₹ 16.65B | ₹ 22.53B | ₹ 20.22B | ₹ 18.68B | ₹ 18.14B | |
| ₹ 11.38B | ₹ 11.39B | ₹ 11.83B | ₹ 11.19B | ₹ 11.16B | |
| Depreciation and Amortization | ₹ 664.40M | ₹ 667.92M | ₹ 696.80M | ₹ 657.67M | ₹ 681.86M |
| ₹ 14.75B | ₹ 13.28B | ₹ 8.88B | ₹ 9.04B | ₹ 8.49B | |
| ₹ 12.60B | ₹ 11.14B | ₹ 8.38B | ₹ 7.48B | ₹ 6.99B | |
| ₹ 1.46B | ₹ 1.46B | ₹ -222.98M | ₹ 879.74M | ₹ 748.15M | |
| ₹ 14.06B | ₹ 12.60B | ₹ 8.16B | ₹ 8.36B | ₹ 7.79B | |
| ₹ 10.36B | ₹ 9.28B | ₹ 5.90B | ₹ 6.11B | ₹ 16.95B | |
| Per Share Metrics | |||||
| Basic EPS | ₹ 61.15 | ₹ 54.76 | ₹ 34.83 | ₹ 35.87 | ₹ 100.04 |
| Diluted EPS | ₹ 61.15 | ₹ 54.76 | ₹ 34.83 | ₹ 35.87 | ₹ 100.04 |
| Weighted Average Shares Outstanding | 169.42M | 169.41M | 169.41M | 169.41M | 169.41M |
| Weighted Average Shares Outstanding (Diluted) | 169.42M | 169.41M | 169.41M | 169.41M | 169.41M |
Currency in INR

